🇺🇸 FDA
Pipeline program

Bioequivalence clinical trial of two formulations of canagliflozin

N-CAN-25-302

Phase 1 other active

Quick answer

Bioequivalence clinical trial of two formulations of canagliflozin for Healthy volunteers is a Phase 1 program (other) at Laboratorios Tillomed Spain S.L.U with 1 ClinicalTrials.gov record(s).

Program details

Company
Laboratorios Tillomed Spain S.L.U
Indication
Healthy volunteers
Phase
Phase 1
Modality
other
Status
active

Clinical trials